The Liver Tumor Program's principle areas of research span from basic science to clinical research, with particular emphasis on tumor biology and the identification of new targets for therapies.

Research investigators in the Texas Children’s Cancer Center have ongoing studies focused on understanding the pathogenesis, biology, and malignant determinants of liver tumors and developing novel therapies.

These studies range from molecular genetic studies to novel clinical trials for treatment of recurrent or refractory disease. Currently, we are working with the Children’s Oncology Group (COG) on an upfront trial for hepatoblastoma, as well as new drug trials.

Our researchers    Our laboratories    Our clinical trials